FastWave Artero
Peripheral Artery Disease (PAD) - calcific lesions
Key Facts
About Fastwave Medical
FastWave Medical is an emerging, award-winning player in the cardiovascular device space, specifically targeting the multi-billion dollar market for calcified artery disease with its advanced intravascular lithotripsy (IVL) platforms. The company has developed two distinct product lines: the FastWave Artero for peripheral artery disease (PAD) and the FastWave Sola for coronary artery disease (CAD), both designed to improve upon existing IVL technology with features like enhanced deliverability, predictable energy output, and user-friendly feedback. Having received notable industry accolades in 2025, FastWave appears to be in a late-stage development or early commercial preparation phase, backed by endorsements from key opinion leaders in interventional cardiology and vascular surgery. As a private company, its near-term trajectory will depend on successful regulatory clearance, market entry, and execution against established competitors.
View full company profile